Literature DB >> 9747382

The association of HLA-DQ7 with bullous pemphigoid is restricted to men.

C C Banfield1, F Wojnarowska, J Allen, S George, V A Venning, K I Welsh.   

Abstract

This study examines in detail the HLA associations of 74 patients (40 women and 34 men) with bullous pemphigoid (BP) and compares their immunogenetic profile with that of 604 unrelated control subjects (238 women and 366 men). Correlations were sought between HLA antigens and the various BP disease parameters investigated. The presence of milia was the only clinical or laboratory finding which was linked with a specific HLA antigen, HLA-DQ6, in both men and women with BP (P < 0.01). BP has previously been linked with the HLA-DQ7 antigen and this association was confirmed in 39 of our patients (14 women and 25 men). Twelve of these patients (four women and eight men) were homozygous for HLA-DQ7. The association of HLA-DQ7 with BP was gender-restricted and only significant for men (P < 0.01). No equivalent HLA disease susceptibility risk factor could be identified for our female BP patients. This difference in HLA association between men and women with BP has not been reported previously, and its significance for disease pathogenesis is not known. No specific link could be found between HLA-DQ7 and BP for any of the clinical, immunofluorescence, western blotting, treatment or prognostic disease factors studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747382     DOI: 10.1046/j.1365-2133.1998.02350.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  T cell control in autoimmune bullous skin disorders.

Authors:  Michael Hertl; Rüdiger Eming; Christian Veldman
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 4.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample.

Authors:  Sebastián Vernal; Ederson Valei de Oliveira; Roberto Bueno Filho; Tamiris A Julio; Eduardo A Donadi; Aline Turatti; Norito Ishii; Takashi Hashimoto; Ana Maria Roselino
Journal:  An Bras Dermatol       Date:  2022-05-27       Impact factor: 2.113

Review 6.  Multiple milia formation in blistering diseases.

Authors:  Aikaterini Patsatsi; Cybill Dianne C Uy; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2020-04-01

Review 7.  Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.

Authors:  Tianyu Cao; Shuai Shao; Hui Fang; Bing Li; Gang Wang
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 8.  Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes.

Authors:  A Razzaque Ahmed; Sarah Anwar; Pedro A Reche
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

Review 9.  The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.

Authors:  Hui Fang; Yang Zhang; Ning Li; Gang Wang; Zhi Liu
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 10.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.